title: Severe rhabdomyolysis during a hypersensitivity reaction to abacavir in a patient treated with ciprofibrate.
authors.forename: Camille
authors.initials: C
authors.lastname: Fontaine
authors.forename: Jean-Baptiste
authors.initials: JB
authors.lastname: Guiard-Schmid
authors.forename: Laurence
authors.initials: L
authors.lastname: Slama
authors.forename: Aben
authors.initials: A
authors.lastname: Essid
authors.forename: Tuna
authors.initials: T
authors.lastname: Lukiana
authors.forename: Eric
authors.initials: E
authors.lastname: Rondeau
authors.forename: Gilles
authors.initials: G
authors.lastname: Pialoux
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects*; D002995:Clofibric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D015224:Dideoxynucleosides / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000209:etiology*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D058607:Fibric Acids; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D006949:Hyperlipidemias / Q000517:prevention & control; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012206:Rhabdomyolysis / Q000139:chemically induced*; D000099227:Abacavir
chemical_list: D019380:Anti-HIV Agents; D002995:Clofibric Acid; D015224:Dideoxynucleosides; D058607:Fibric Acids; D000960:Hypolipidemic Agents; D000099227:Abacavir; C019304:ciprofibrate